Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes

BackgroundThe apolipoprotein A5 gene (APOA5) -1131 T > C polymorphism is associated with mild hypertriglyceridemia in type 2 diabetic subjects, and interacts with dietary fat in the determination of triglyceride concentrations. We examined whether a substitution of whole grains and legumes for refined rice in a high carbohydrate diet (about 65% of energy derived from carbohydrate) may modify the effect of this variant on changes in apolipoprotein A-V (apoA-V) and triglyceride concentrations.MethodsWe genotyped the APOA5 -1131 T > C in individuals with impaired fasting glucose (IFG) or newly diagnosed type 2 diabetes, who were randomly assigned to either a group ingesting whole grain and legume meals daily or a control group for 12 weeks.ResultsAfter dietary intervention, we observed significant interactions between the APOA5 -1131 T > C polymorphism and carbohydrate sources (whole grains and legumes versus refined rice) in the determination of mean percent changes in triglyceride and apoA-V (P interactions <0.001 and =0.038, respectively). In the refined rice group (n = 93), the carriers of the risk C allele (n = 50) showed a greater increase in the mean percent changes of triglyceride and apoA-V than noncarriers after adjusting for HOMA-IR (P = 0.004 and 0.021, respectively). The whole grain and legume group (n = 92), however, showed a decrease in fasting glucose, HOMA-IR, and triglyceride, and an increase in apoA-V, irrespective of genotype.ConclusionsThe data showed that the magnitude of the genetic effect of the APOA5 -1131C variant on triglyceride and apoA-V levels was modulated when substituting consumption of whole grains and legumes for refined rice as a carbohydrate source in IFG or diabetic subjects.Trial registrationClinicalTrials.gov: NCT01784952.

[1]  P. Kris-Etherton,et al.  The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. , 2008, The American journal of clinical nutrition.

[2]  C. Nam,et al.  A Study on Validity of a Semi-Quantitative Food Frequency Questionnaire for Korean Adults , 2002 .

[3]  J. Hubacek,et al.  Changes of Plasma Lipids during Weight Reduction in Females Depends on APOA5 Variants , 2008, Annals of Nutrition and Metabolism.

[4]  N. Colburn,et al.  A High Legume Low Glycemic Index Diet Improves Serum Lipid Profiles in Men , 2010, Lipids.

[5]  Jia Lin,et al.  Elevated Levels of Triglyceride and Triglyceride-Rich Lipoprotein Triglyceride Induced by a High-Carbohydrate Diet Is Associated with Polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese Healthy Young Adults , 2011, Annals of Nutrition and Metabolism.

[6]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[7]  J. H. Lee,et al.  Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men. , 2009, Atherosclerosis.

[8]  J. Ordovás,et al.  Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. , 2009, The Journal of nutrition.

[9]  M. Nagano,et al.  A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration Published, JLR Papers in Press, June 16, 2005. DOI 10.1194/jlr.D500018-JLR200 , 2005, Journal of Lipid Research.

[10]  N. Lauder Handbook of clinical dietetics , 1982 .

[11]  Jonathan C. Cohen,et al.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. , 2002, Human molecular genetics.

[12]  E. Sijbrands,et al.  Plasma apolipoprotein A5 and triglycerides in type 2 diabetes , 2006, Diabetologia.

[13]  James W. Anderson,et al.  Meta-analysis of the effects of soy protein intake on serum lipids. , 1995, The New England journal of medicine.

[14]  S. Soyal,et al.  Determinants of plasma apolipoprotein A‐V and APOA5 gene transcripts in humans , 2008, Journal of internal medicine.

[15]  D. Arveiler,et al.  The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides , 2008, BMC Medical Genetics.

[16]  P. Moulin,et al.  Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[17]  M. Prince,et al.  Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[18]  X. Adiconis,et al.  Dietary Intake of n-6 Fatty Acids Modulates Effect of Apolipoprotein A5 Gene on Plasma Fasting Triglycerides, Remnant Lipoprotein Concentrations, and Lipoprotein Particle Size: The Framingham Heart Study , 2006, Circulation.

[19]  T. Frayling,et al.  Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans , 2006, BMC Medical Genetics.

[20]  J. Ordovás,et al.  APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. , 2011, The Journal of nutrition.

[21]  G A Colditz,et al.  Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. , 1992, American journal of epidemiology.

[22]  X. Adiconis,et al.  The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.M300251-JLR200 , 2003, Journal of Lipid Research.

[23]  M. Olivier,et al.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. , 2002, Human molecular genetics.

[24]  J. Danesh,et al.  Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies , 2010, The Lancet.

[25]  J. H. Lee,et al.  APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects. , 2010, Atherosclerosis.

[26]  J. H. Lee,et al.  The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[27]  T. Temelkova-Kurktschiev,et al.  Lifestyle and genetics in obesity and type 2 diabetes. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[28]  P. Talmud,et al.  Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Published, JLR Papers in Press, July 21, 2006. , 2006, Journal of Lipid Research.

[29]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[30]  K. V. van Dijk,et al.  Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. , 2007, Atherosclerosis.

[31]  Shotai Kobayashi,et al.  The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. , 2002, Atherosclerosis.

[32]  J. H. Lee,et al.  Comparison of Low-Fat Meal and High-Fat Meal on Postprandial Lipemic Response in Non-Obese Men according to the −1131T>C Polymorphism of the Apolipoprotein A5 (APOA5) Gene (Randomized Cross-Over Design) , 2006, Journal of the American College of Nutrition.

[33]  D. Corella,et al.  APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study , 2007, Journal of Molecular Medicine.

[34]  M. Nieminen,et al.  APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. , 2004, Journal of lipid research.

[35]  S. Ho,et al.  Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. , 2005, The American journal of clinical nutrition.

[36]  J. Ordovás,et al.  The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk , 2005, Current opinion in lipidology.